Welcome to our dedicated page for Life360 SEC filings (Ticker: LIF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Life360, Inc. filings document regulatory disclosures for a Delaware technology company whose common stock trades on Nasdaq under LIF. Form 8-K reports furnish operating and financial results, Regulation FD presentation materials, material-event disclosures, material agreements, shareholder voting matters and capital-structure information.
Proxy materials describe board and executive compensation matters, equity awards, corporate governance and voting procedures. The filing record also reflects disclosure areas tied to Life360’s family safety platform, subscription metrics, advertising initiatives, legal and compliance oversight, and public-company securities reporting.
Life360, Inc. reported stronger Q3 2025 results. Total revenue reached $124.5 million, up from $92.9 million a year ago, led by subscription revenue of $96.3 million. Gross profit was $97.1 million. Operating income improved to $5.7 million, and net income was $9.8 million, compared with $7.7 million in Q3 2024.
The company ended the quarter with cash and cash equivalents of $455.7 million. In June, Life360 issued $320.0 million of 0.00% convertible senior notes due 2030 and purchased capped calls for $33.7 million to mitigate potential dilution. Current deferred revenue was $46.1 million, and remaining performance obligations were $225.3 million. Channel concentration remained high, with Apple processing 54% of transactions and Google 21%. Legal overhang eased as the Tile patent case was settled at no cost, and certain class claims were dismissed with prejudice while others are stayed pending appeal.
Life360, Inc. (LIF) director John P. Coghlan reported open‑market sales on 11/03/2025 made under a Rule 10b5‑1 trading plan adopted on December 6, 2024. The transactions included 2,866 shares at a weighted average price of $98.88 and 259 shares at a weighted average price of $99.47.
Following the transactions, beneficial ownership reported included 15,235 shares held by the John Coghlan Living Trust, 3,344 shares held directly, and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. Holdings include 2,508 restricted stock units. The filing also notes an exempt transfer of 12,110 shares from the GRAT to the Living Trust pursuant to Rule 16a‑13.
Life360, Inc. (LIF) Chief Executive Officer and Director reported a sale of 4,546 shares of common stock on 10/24/2025 at a price of $93.01 per share, coded “S.” The trade was made pursuant to a Rule 10b5-1 trading plan adopted on November 27, 2024.
Following the transaction, the reporting person beneficially owns 329,373 shares directly. This amount includes 222,277 restricted stock units (RSUs), each representing a contingent right to receive one share upon vesting.
Life360 (LIF) reported an insider transaction: a company director filed a Form 4 for activity on October 13, 2025. The reporting person exercised 7,930 stock options at an exercise price of $11.18 per share and, on the same date, sold 7,930 shares at a price of $103.20 per share. The transactions were executed under a Rule 10b5-1 trading plan adopted on March 14, 2025.
Following these transactions, the reporting person beneficially owned 105,456 shares of common stock. This figure includes 2,036 restricted stock units, each representing a right to receive one share upon vesting. The exercised option relates to a grant with a vesting schedule that began April 12, 2024 and monthly thereafter, and carries an expiration date of April 12, 2028.
John Philip Coghlan, a director of Life360, Inc. (LIF), reported multiple dispositions of common stock effected on 10/01/2025. The filing shows sales under a Rule 10b5-1 trading plan adopted on 12/06/2024. Reported transactions include dispositions of 2,701 shares at a weighted average price of $105.28 (prices ranged $104.84–$105.73), 424 shares at a weighted average of $105.99 (range $105.84–$106.05), and 3,344 shares (note: includes 2,508 restricted stock units) with beneficial ownership changes reported as indirect holdings in the John Coghlan Living Trust and the John Philip Coghlan 2025 Grantor Retained Annuity Trust. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Life360, Inc. (LIF) insider filing to sell common stock. The filing notifies a proposed sale of 9,375 shares of common stock through The Charles Schwab Corporation with an aggregate market value of $989,063.00, approximately to occur on 10/01/2025 on NASDAQ. The shares were acquired in a private purchase from the issuer on 09/26/2011. The filer reports three sales in the past three months totaling 16,250 shares for gross proceeds of $1,355,344.00 (sales on 08/01/2025, 08/15/2025, and 09/02/2025). The notice includes the usual representation that the selling person is not aware of undisclosed material adverse information.
Life360 insider sale under pre-set plan Lauren Antonoff, who serves as Chief Executive Officer and a director of Life360, Inc. (LIF), reported the sale of 4,546 shares of the company's common stock on 09/24/2025 at a price of $101.52 per share. The filing states the sale was executed under a Rule 10b5-1 trading plan adopted on November 27, 2024, which the reporting person says was established when they were not aware of any material nonpublic information.
The Form 4 shows the reporting person beneficially owns 333,919 shares following the transaction, which includes 222,277 restricted stock units that convert to common shares upon vesting. The form is signed by an attorney-in-fact and provides the required disclosure of relationship and transaction details.
Life360, Inc. Form 144: An officer or other person plans to sell 4,546 shares of Life360 common stock on 09/24/2025, with an aggregate market value reported as $461,509.92 and the sale venue listed as NASDAQ. The shares were acquired on 06/20/2024 through restricted stock vesting and were received as compensation. The filer also reported four prior sales over the past three months totaling 36,502 shares with reported gross proceeds of $2,482,157.96 across dates from 06/24/2025 to 09/05/2025. The filer certifies no undisclosed material adverse information in connection with this notice.
Charles J. Prober, a director of Life360, Inc. (LIF), reported transactions on 09/15/2025 conducted under a Rule 10b5-1 trading plan. The Form 4 shows an acquisition of 7,930 shares via exercise of stock options at an $11.18 exercise price and a contemporaneous sale of 7,930 shares at $100.24 per share. After the transactions the reporting person’s direct beneficial ownership is reported as 105,456 shares in one line and 111,020 options-related shares in the derivative table; the filing also notes total holdings include 2,036 restricted stock units that convert to common stock upon vesting. The Form 4 states the 10b5-1 plan was adopted on March 14, 2025, and the option vesting schedule is described in the filing.
Life360, Inc. submitted a Rule 144 notice proposing the sale of 7,930 common shares through Fidelity Brokerage Services on 09/15/2025 with an aggregate market value of $794,903.20. The filing reports 77,548,651 shares outstanding. The securities were acquired on 09/15/2025 as options originally granted on 04/12/2022 and the stated payment method is cash. The form also discloses two prior sales by Charles Prober within the past three months: 7,930 shares sold on 07/14/2025 for $510,771.30 and 7,930 shares sold on 08/13/2025 for $667,150.90. The filer attests there is no undisclosed material adverse information.